Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-488410
- Development stage
- Phase 2
- Lead developer
- Shionogi
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
S-488410 is an investigational, HLA-A*2402-restricted therapeutic multipeptide cancer vaccine developed from three tumor-associated cancer-testis antigens: URLC10, CDCA1, and KIF20A. The fixed peptide cocktail is intended to prime antigen-specific cytotoxic T-lymphocyte responses against tumor cells that express these antigens. It was studied by subcutaneous administration in patients with advanced non-small cell lung cancer and in advanced or recurrent esophageal squamous cell carcinoma. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01592617))
- Other names
- HLA-A*2402-restricted multipeptide vaccine S-488410S 488410S488410S-488410
02
Targets
T-cell receptor (TCR) recognizing S-488410 peptide–HLA-A*24:02 complexesHLA-A*24 (Major histocompatibility complex class I molecule presenting MAGE-A4 peptide)
Beyond the preview
Go deeper on S-488410.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S-488410.